TABLE 1

Suggested Priority for Dispensing PDHM

Recipient factors to considerMaternal factors to consider
 • Age • Insufficient milk supply
 • Projected length of need • Medical contraindication to breastfeeding
 • Medical condition • Adoption
 • Prognosis • Choice
 • Prevention of problems
 • Research
 • Ability to pay (may be a factor where medical need is not evident)
Time factors to considerEthical values
 • Short-term use • Community benefit
 • Likely to recover • Individual benefit and choice
 • Preventive treatment
Priority from highest to lowest
 1. Premature infants, sick
 2. Premature infants, well
 3. Infants <12 mo old with medical conditions likely to respond to PDHM therapy
 4. Patients >12 mo old with medical conditions likely to respond to PDHM therapy
 5. Research contracts for clinical use in well-designed studies
 6. Patients >12 mo old with chronic medical conditions and high normal functioning and low-dose need for PDHM therapy
 7. Patients >12 mo old with chronic medical conditions and high normal functioning and high-dose need for PDHM therapy
 8. Patients >12 mo old with chronic medical conditions and low-level functioning and low-dose need for PDHM therapy
 9. Patients >12 mo old with chronic medical conditions and low-level functioning and high-dose need for PDHM therapy
 10. Infants for short-term use, no specific medical condition
 11. Laboratory research (milk that cannot be used for human consumption because of drugs used by the donor or lack of complete testing of the donor)
  • Human Milk Banking Association of North America13.